China Resources Double Crane Faces Revenue Decline Amid Innovative Drug Sector Growth
China Resources Double Crane Pharmaceutical Co Ltd reported a 3.16% decline in revenue and 6.79% decrease in net profit for the first half of 2025, but remains a key player in the pharmaceutical industry with opportunities in the growing innovative …
- China Resources Double Crane Pharmaceutical Co Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read